Clinical Trials Logo

Filter by:
NCT ID: NCT04989595 Completed - Clinical trials for Uterine Bleeding Profile Prediction

A Study to Learn More About How a Smartphone App Called MyIUS Predicts Future Menstrual Bleeding in Women After They Have Begun Using Intrauterine Birth Control Method (a Birth Control Device is Inserted Into a Woman's Uterus by Her Doctor)

MyIUS
Start date: September 17, 2021
Phase:
Study type: Observational

Researchers are looking to learn more about future menstrual bleeding in women who have started using intrauterine contraception methods. "Intrauterine contraception" means that a device is inserted into a woman's uterus by her doctor. The device then releases a birth control treatment into the uterus. Researchers have found that when women use intrauterine contraception, its effects on the menstrual cycle can cause changes to how often and for how long women will bleed. This is one of reasons women may stop using their intrauterine contraception. So, the researchers in this study wanted to learn about a tool that can be used to predict future bleeding events. This tool was developed based on the results of previous clinical studies that researched menstrual bleeding. This tool is a smartphone application called MyIUS. This study will include about 3,000 women who have recently had intrauterine contraception inserted and who use the MyIUS app. There will be no visits with a study doctor in this study. After the intrauterine contraception has been inserted, the women will start to record any events of bleeding in the MyIUS app. After they have recorded events of bleeding for a total of 90 days, the MyIUS app will give a prediction of menstrual bleeding expected for the next 180 days. The women who sign the electronic informed consent form will continue to record their bleeding events for a total of 6 months. The researchers will then collect this information. They will use this information to find out how well the MyIUS app can predict future menstrual bleeding.

NCT ID: NCT04988633 Completed - Clinical trials for Non-Alcoholic Fatty Liver Disease

"CAP" Fetge Gras. Lifestyle Modification Program in Catalonia.

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

The main purpose of this study is to investigate whether an online lifestyle modification program for people with Metabolic Associated Fatty Liver Disease (MAFLD) through a mobile application produces a significant reduction in liver steatosis and is associated with a higher rate of weight loss compared to standard recommendations currently indicated in Primary Care.

NCT ID: NCT04988594 Completed - Type2 Diabetes Clinical Trials

Effects of Yogurt With Probiotics in Adults With Type 2 Diabetes Mellitus

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to analyze the effects of the consumption of yogurt with concentrated and lyophilized probiotic cultures on the parameters associated with glucose homeostasis, inflammation and oxidative stress in patients with Type 2 Diabetes Mellitus (T2DM).

NCT ID: NCT04987619 Completed - Muscular Endurance Clinical Trials

Effect of Beetroot Juice Supplements on Lower-limb Strength in Females

Start date: July 5, 2021
Phase: N/A
Study type: Interventional

This study aims to evaluate the effects of beetroot juice supplements on lower-limb strength and muscular endurance in physically active women, due to the presence of NO3- in beetroot juice.

NCT ID: NCT04987567 Completed - Clinical trials for Cystic Fibrosis in Children

Effect of Antioxidant Docosahexaenoic Acid (DHA) in Cystic Fibrosis Patients

Start date: March 21, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effect of antioxidant docosahexaenoic acid (DHA) in patients with cystic fibrosis. Half of participants will receive DHA, while the other half will receive placebo.

NCT ID: NCT04987034 Completed - Liver Cirrhosis Clinical Trials

Comparing a Direct Versus an Indirect Approach to Measuring the Portalsytemic Pressure Gradients

Start date: July 27, 2021
Phase:
Study type: Observational

The objective of this study is to evaluate the correlation of the calculated portosystemic pressure gradient (PPG) obtained by direct portal and hepatic pressure measurements with the EchoTip® Insightâ„¢ and indirect portal vein pressure measurements using the interventional radiology based hepatic venous pressure gradient (HVPG) procedure.

NCT ID: NCT04986449 Completed - Family Research Clinical Trials

Nutritional and Culinary Habits to Empower Families - A Feasibility Study

n-CHEF
Start date: April 4, 2021
Phase: N/A
Study type: Interventional

Background: Currently, one of the health challenges in the field of public health is to improve the quality of life of people with metabolic diseases, using new strategies to promote eating habits and lifestyle that allow an active involvement in health. Within the new strategies to promote an improvement in the eating habits of the population, culinary-nutritional interventions based on culinary medicine or strategies such as home-cooking, have been proposed as effective measures for the implementation of healthy eating habits in the population. Intervention with families (the environment in which the eating habits of children are implemented for the future) should be highlighted. Methods: The present project will cover culinary medicine and home-cooking as innovative strategies to improve the eating habits of families through an intervention based on face-to-face (2) and online (2) cooking workshops, where apart from receiving nutritional education, they will be taught a series of culinary techniques (adapted to adults and children) so that they learn to cook in an easy, enjoyable and family-friendly way, with tools to eat healthier in a simple and quick way. The main objective is to evaluate the feasibility of the culinary-nutritional intervention. The intervention will be carried out with 15 families (one of the parents and one of the children of the family aged between 10 and 14 years), through the measurement of anthropometric parameters and questionnaires on eating habits and lifestyles (both individual and family). In addition, questionnaires specific to the research will be collected in order to study the feasibility of the intervention.

NCT ID: NCT04985812 Completed - Clinical trials for Rheumatoid Arthritis

A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis

Start date: October 18, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate safety and tolerability of JNJ-67484703 administrations in participants with active rheumatoid arthritis (RA).

NCT ID: NCT04985097 Completed - Clinical trials for Visual Acuity Reduced Transiently

Home-based Visual Training in Patients Implanted With Trifocal Diffractive Intraocular Lenses

OPTicTRAIN
Start date: September 1, 2018
Phase: N/A
Study type: Interventional

This multicentre randomised controlled trial aimed to reduce the visual discomfort that patients implanted with trifocal diffractive intraocular lenses may experience after surgery. To this end, a visual training software (Optictrain) was developed in which Gabor patches were presented to the patient on a hand-held electronic device. Patients who met all inclusion criteria and consented to participate underwent half an hour of visual training per day for a period of 20 consecutive days remotely on a colourimetrically characterised Samsung Galaxy Tab A device on which the Optictrain software (n=30) or a placebo software (n=30), respectively, was pre-installed. Corrected and uncorrected near, intermediate and distance visual acuity (VA) and mesopic near and distance contrast sensitivity (CS) were measured monocularly and binocularly at two visits: during the first postoperative week (V0) and after 20 days of visual training with the assigned software (V1). The statistical analysis of the results obtained in the study has not yet been carried out.

NCT ID: NCT04983238 Completed - Clinical trials for Metastatic Breast Cancer

Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985

Start date: January 10, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This multicenter, randomized, double-blind, placebo-controlled trial with a single arm run-in period is to evaluate the safety and efficacy of sodium thiosulfate (BYON5667) eye drops to reduce ocular toxicity in cancer patients treated with the antibody-drug conjugate (ADC) SYD985